drugset / Trial / NCT02350205

SASS 2 : Self Assembled Skin Substitute for the Autologous Treatment of Severe Burn Wounds in Acute Stage of Burn Trauma

NCT02350205 ↗

Phase 1/2 Recruiting 52 enrolled CHU de Quebec-Universite Laval
NaSingle-groupOpen-labelTreatment

Summary

This clinical trial is designed to assess the safety, effectiveness and benefits of Self Assembled Skin Substitute SASS grafts as a permanent skin replacement for the treatment of full-thickness burn wounds that require permanent coverage where the availability of donor sites is limited.

Timeline

Start
2015-12
Primary completion
2028-01
Completion
2029-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Self assembled skin substitute Unknown — —

Indications

No indication recorded.